Studies by de Luis et al. and Prasad et al. reported similar findings, suggesting that decreased adiponectin contributes to the heightened risk of type 2 diabetes and cardiovascular complications in obese PCOS patients [16,17]. Here, ADIPOQ is linked to type 2 diabetes mellitus.